{
  "cik": 1750284,
  "cik_padded": "0001750284",
  "entityName": "Olema Pharmaceuticals, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-107169",
      "filed": "2026-03-16",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 48301000.0,
        "eps_diluted": -1.87,
        "net_income": -162451000.0,
        "operating_cash_flow": -146716000.0,
        "operating_income": -178698000.0,
        "stockholders_equity": 478559000.0,
        "total_assets": 533430000.0,
        "total_liabilities": 54871000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.11465879860163533,
        "roa_avg2y": -0.33004777485780806,
        "roa_period_end": -0.30454042704759765,
        "roe_avg2y": -0.36607727349037716,
        "roe_period_end": -0.33945866653850415
      }
    },
    {
      "accn": "0001193125-26-107169",
      "filed": "2026-03-16",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 159000.0,
        "cash": 139480000.0,
        "eps_diluted": -2.2,
        "free_cash_flow": -104510000.0,
        "net_income": -129474000.0,
        "operating_cash_flow": -104351000.0,
        "operating_income": -142258000.0,
        "stockholders_equity": 408964000.0,
        "total_assets": 450979000.0,
        "total_liabilities": 42015000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.10273520407664244,
        "roa_avg2y": -0.3557349393618015,
        "roa_period_end": -0.28709540799017247,
        "roe_avg2y": -0.3906532158422832,
        "roe_period_end": -0.31659021331950976
      }
    },
    {
      "accn": "0001193125-26-107169",
      "filed": "2026-03-16",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 68539000.0,
        "eps_diluted": -2.14,
        "net_income": -96655000.0,
        "operating_cash_flow": -83727000.0,
        "operating_income": -104961000.0,
        "stockholders_equity": 253895000.0,
        "total_assets": 276945000.0,
        "total_liabilities": 23050000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.09078556096023947,
        "roa_avg2y": -0.39243590003857165,
        "roa_period_end": -0.3490043149361787,
        "roe_avg2y": -0.4282065651989961,
        "roe_period_end": -0.38068886744520375
      }
    },
    {
      "accn": "0000950170-25-041204",
      "filed": "2025-03-18",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 363000.0,
        "cash": 23702000.0,
        "eps_diluted": -2.62,
        "free_cash_flow": -82428000.0,
        "net_income": -104787000.0,
        "operating_cash_flow": -82065000.0,
        "operating_income": -106988000.0,
        "stockholders_equity": 197546000.0,
        "total_assets": 215645000.0,
        "total_liabilities": 18099000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.09161916718131473,
        "roa_avg2y": -0.40965226059930804,
        "roa_period_end": -0.485923624475411,
        "roe_avg2y": -0.43469801748134257,
        "roe_period_end": -0.530443542263574
      }
    },
    {
      "accn": "0001558370-23-003318",
      "filed": "2024-03-11",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1575000.0,
        "cash": 13812000.0,
        "eps_diluted": -1.8,
        "free_cash_flow": -52265000.0,
        "net_income": -71096000.0,
        "operating_cash_flow": -50690000.0,
        "operating_income": -71491000.0,
        "stockholders_equity": 284568000.0,
        "total_assets": 295945000.0,
        "total_liabilities": 11377000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.039979899356217145,
        "roa_avg2y": -0.22263871469795685,
        "roa_period_end": -0.2402338272314112,
        "roe_avg2y": -0.22834568535662955,
        "roe_period_end": -0.2498383514660819
      }
    },
    {
      "accn": "0001558370-23-003318",
      "filed": "2023-03-09",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 56000.0,
        "cash": 338549000.0,
        "eps_diluted": -3.42,
        "free_cash_flow": -19922000.0,
        "net_income": -22121000.0,
        "operating_cash_flow": -19866000.0,
        "operating_income": -21528000.0,
        "stockholders_equity": 338137000.0,
        "total_assets": 342722000.0,
        "total_liabilities": 4585000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.013559592709463915,
        "roa_period_end": -0.06454502483062073,
        "roe_avg2y": -0.13507234164674561,
        "roe_period_end": -0.06542022907874619
      }
    },
    {
      "accn": "0001558370-22-002388",
      "filed": "2022-02-28",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "eps_diluted": -1.66,
        "net_income": -4316000.0,
        "operating_cash_flow": -3081000.0,
        "operating_income": -4323000.0,
        "stockholders_equity": -10594000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roe_avg2y": 0.4545310936759518
      }
    },
    {
      "accn": "0001558370-22-002388",
      "filed": "2022-02-28",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -8397000.0
      },
      "period_end": "2018-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-107169",
    "filed": "2026-03-16",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001750284.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001750284.json"
  },
  "ticker": "OLMA"
}